A new "fluid biopsy" technique that could identify patients at very high risk of a heart attack by identifying specific cells as markers in the bloodstream has been developed by a group of researchers in the US.
The technique, which has been described today, 10 January, in IOP Publishing's journal Physical Biology, works by identifying circulating endothelial cells (CECs) and has been successful in distinguishing patients undergoing treatment for a recent heart attack with a healthy control group.